From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Neil Woodford Redemptions Watch: One step for a small man........it's all over bar the shouting

By Nigel Somerville | Tuesday 15 October 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


And so Link, the Authorised Corporate Director of Woodford Equity Income (WEIF) – Neil Woodford’s flagship fund and the main source of income for Woodford Investment Management – has announced that Woodford has been sacked as fund manager, and that rather than be un-gated come December the fund is being wound down. In other words it is in full redemption mode. It will be interesting to see how much of the £3.025 billion it was supposedly worth at yesterday’s close will survive the fire sale which surely follows. But what of the other two Woodford funds, Income Focus and Woodford Patient Capital (WPCT)?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 08:04:33